Sign in
4

Changes in Ownership

LENZ Therapeutics, Inc. Filed Acc 0002015796-25-000003

Chief Commercial Officer sold 10,000 shares at an average $26.10 ($261,022)

  • Chief Commercial Officer acquired 10,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Olsson Shawn Chief Commercial Officer 2025-11-17 Option exercise 10b5-1 +10,000 $2.08 $20,800 14,733 D
Olsson Shawn Chief Commercial Officer 2025-11-17 Sale 10b5-1 −4,212 $25.74 $108,411 10,521 D
Olsson Shawn Chief Commercial Officer 2025-11-17 Sale 10b5-1 −5,788 $26.37 $152,612 4,733 D
Derivatives
Olsson Shawn Chief Commercial Officer 2025-11-17 Option exercise · Stock Option (right to buy) 10b5-1 −10,000 53,241 D
Open-market sales · 10,000 sh · avg $26.10 · $261,022
Loading xslF345X05/wk-form4_1763596932.xml…